Work

ADS-5102 provided reduction in motor complications in Parkinson’s disease patients with levodopa-induced dyskinesia switched from amantadine IR: Subgroup analysis from open-label study (ease LID 2)

Year: 2017

Type: conference-abstract

Source: Journal of the Neurological Sciences

DOI: 10.1016/j.jns.2017.08.1008

Authors: S. Isaacson, R. Pahwa, C. Tanner, S. Fahn, A. Espay, C. Trenkwalder, R. Patni

Institutions: University of Kansas Medical Center, San Francisco VA Medical Center, University of California, San Francisco, Columbia University, University of Cincinnati, Paracelsus Elena Klinik Kassel, Adamas Pharmaceuticals (United States)

Language: English

Topic: Parkinson's Disease Mechanisms and Treatments

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2771874897

Cites:

Cited by: 3

Related to: 10